Avanos Medical (AVNS) Divestments (2018 - 2024)

Avanos Medical's (AVNS) quarterly Divestments came in at -$2.1 million in Q4 2024, down 102.36% year-on-year from $89.0 million in Q1 2024, and down 200.0% quarter-over-quarter from $2.1 million in Q1 2024.

Avanos Medical (AVNS) Divestments (2018 - 2024) Analysis & Trends

Avanos Medical has disclosed Divestments across 3 years of filings, most recently posting -$2.1 million for Q4 2024.

  • Divestments for Q4 2024 came in at -$2.1 million, down 102.36% year-over-year; the trailing twelve-month figure through Sep 2025 was -$2.1 million (down 102.31% YoY), and the FY2023 annual result was $89.0 million, changed N/A from the prior year.
  • Divestments came in at -$2.1 million for Q4 2024 at Avanos Medical, down from $2.1 million in the prior quarter.
  • In the past five years, Divestments ranged from a high of $89.0 million in Q4 2023 to a low of -$2.1 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 9.37 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Avanos Medical 1.16 Bn 1.09 Bn 94.20 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 -2.10 Mn
Mar 31, 2024 2.10 Mn
Dec 31, 2023 89.00 Mn
Sep 30, 2018 19.80 Mn